RecruitingPhase 1

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for PCOS

Antigua and Barbuda, Greece20 participantsStarted 2023-11-16

Plain-language summary

This trial will study the safety and efficacy of cultured allogeneic adult umbilical cord derived mesenchymal stem cells delivered intravenously for the treatment of Polycystic Ovary Syndrome.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: • Ultrasound documented poly cystic ovary syndrome Exclusion Criteria: * Active infection * Active cancer * Chronic multisystem organ failure * Pregnancy * Clinically significant abnormalities on pre-treatment laboratory evaluation * Medical condition that would (based on the opinion of the investigator) compromise patient's safety * Continued drug abuse * Previous organ transplant * Hypersensitivity to sulfur * Inability to supply proper informed consent

What they're measuring

Safety: Adverse Events

Timeframe: Four year follow-up

Trial details

NCT IDNCT06143527

SponsorThe Foundation for Orthopaedics and Regenerative Medicine

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-11-16

Contact for this trial

Chadwick C Prodromos, MD

8476996810 research@ismoc.net

View on ClinicalTrials.gov More Polycystic Ovary Syndrome (PCOS) trials